Yu will be responsible for Yongye Biotechnology’s financial planning, control and reporting activities. Before joining Yongye Biotechnology, he provided consulting services to help Chinese companies in listing on Nasdaq Stock Market. Before that, he served as chief operating officer of Lionax International Investment Holding Ltd, where he was responsible for developing company’s business strategy and oversaw the manufacturing, finance and other major operations. He also helped the company with its listing on the Euronext Stock Exchange. Previously in his career, Yu served as general manager and manager of financial analysis at Underwriters Laboratories in its Asia Pacific business division and Chicago global headquarters. He holds an MBA from the Stanford University and a bachelor of economics degree in international accounting from University of International Business and Economics in Beijing. He is fluent in both Mandarin and English.
‘I am excited to join a dynamic and growing company such as Yongye,’ stated Yu. ‘I look forward to applying my experience in accounting, finance, and the capital markets to my new position as CFO, and working with an already impressive management team.’
‘Mr. Yu’s knowledge of accounting, finance and the capital markets will enhance our finance and accounting functions and make him a valuable addition to our team,’ stated Zishen Wu, chief executive officer of Yongye Biotechnology. ‘In addition, his corporate strategy expertise provides even more depth to our management team, and will play a vital role as we continue implementing our growth strategy.’
